Cidara's preventive influenza biologic is effective in Phase 2b trial

Cidara Therapeutics’ long-acting antiviral biologic effectively prevented seasonal flu infections in a mid-stage trial, the biotech said Monday. Its shares {$CDTX} were up 95% in early trade on the Nasdaq. ...